Mark Jerome Pykett - Net Worth and Insider Trading
Mark Jerome Pykett Net Worth
The estimated net worth of Mark Jerome Pykett is at least $1 dollars as of 2025-01-01. Mark Jerome Pykett is the CEO of Navidea Biopharmaceuticals Inc and owns about 14,831 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $1. Details can be seen in Mark Jerome Pykett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Jerome Pykett has not made any transactions after 2014-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Jerome Pykett
Mark Jerome Pykett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Jerome Pykett owns 3 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) , Savara Inc (SVRA) , and Alseres Pharmaceuticals Inc (ALSE) .
Click here to see the complete history of Mark Jerome Pykett’s form 4 insider trades.
Insider Ownership Summary of Mark Jerome Pykett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2014-05-09 | EVP |
| SVRA | Savara Inc | 2004-01-29 | director |
| ALSE | Alseres Pharmaceuticals Inc | 2009-01-14 | President and COO |
Mark Jerome Pykett Latest Holdings Summary
Mark Jerome Pykett currently owns a total of 1 stock. Mark Jerome Pykett owns 14,831 shares of Navidea Biopharmaceuticals Inc (NAVB) as of May 9, 2014, with a value of $1.
Latest Holdings of Mark Jerome Pykett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2014-05-09 | 14,831 | 0.00 | 1 |
Holding Weightings of Mark Jerome Pykett
Mark Jerome Pykett Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Jerome Pykett has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 500 shares on May 9, 2014, which cost Mark Jerome Pykett around $13,400.
Insider Trading History of Mark Jerome Pykett
- 1
Mark Jerome Pykett Trading Performance
GuruFocus tracks the stock performance after each of Mark Jerome Pykett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Jerome Pykett is -0.77%. GuruFocus also compares Mark Jerome Pykett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Jerome Pykett within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Jerome Pykett's insider trading performs compared to the benchmark.
Performance of Mark Jerome Pykett
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 10.08 | | | | | |
| Relative Return to S&P 500(%) | 8.93 | | | | | |
Mark Jerome Pykett Ownership Network
Mark Jerome Pykett Owned Company Details
What does Navidea Biopharmaceuticals Inc do?
Who are the key executives at Navidea Biopharmaceuticals Inc?
Mark Jerome Pykett is the EVP of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .
Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Navidea Biopharmaceuticals Inc Insider Transactions
Mark Jerome Pykett Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Jerome Pykett. You might contact Mark Jerome Pykett via mailing address: 223a Main St, Boxford Ma 021921.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
